Keyphrases
Retrospective Analysis
100%
Tolerability
100%
Brain Tumor Patients
100%
Levetiracetam
100%
Seizure
57%
Antiepileptic Drugs
57%
Seizure Frequency
42%
Tumor
28%
Monotherapy
28%
Seizure Control
28%
Anatomic
14%
N-methyl-D-aspartate Receptor (NMDAR)
14%
Immune Response
14%
Illness
14%
Retrospective Chart Review
14%
Voltage-dependent Activation
14%
Day Range
14%
Unique Mechanism
14%
Common Complications
14%
Neuron-specific
14%
Somnolence
14%
Sign Test
14%
Input Pathway
14%
Add-on Therapy
14%
Novel Mechanism of Action
14%
Brain Tumor
14%
Anticonvulsant
14%
Ca++
14%
Neuronal Damage
14%
Pharmacology, Toxicology and Pharmaceutical Science
Tolerability
100%
Levetiracetam
100%
Brain Tumor
100%
Anticonvulsive Agent
71%
Neoplasm
28%
Calcium Ion
28%
Monotherapy
28%
Disease
14%
Somnolence
14%
N Methyl Dextro Aspartic Acid Receptor
14%
Add on Therapy
14%
Anticonvulsant Therapy
14%
Neuroscience
Brain Tumor
100%
Levetiracetam
100%
Anticonvulsant
57%
Anticonvulsant
28%
NMDA Receptor
14%
Calcium Channel
14%
Somnolence
14%